Vardenafil Hydrochloride
Product Images NDC 71610-310

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 71610-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 20 mg (71610 0310 02)

Vardenafil Hydrochloride 20 mg tablet bottle label showing NDC 71610-0310-02. The label includes storage instructions, manufacturer Lannett Co. Inc., and labeler Aphena Pharma Solutions - Tennessee, LLC located in Cookeville, TN. The package contains 2 tablets and is marked RX Only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Vardenafil Figure 1)

Chemical structure diagram of Vardenafil Hydrochloride, showing its molecular arrangement with noted hydrochloride and hydration components.*

FDA Label Image

Figure 1 (Vardenafil Figure 2)

Three line graphs showing mean maximal changes in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) corresponding to timing of Vardenafil treatment before NTG administration at intervals of 24h, 8h, 4h, and 1h. The graphs illustrate trends in these cardiovascular parameters with error bars indicating variability.*

FDA Label Image

Figure 2 (Vardenafil Figure 3)

A line graph depicting mean change in mmHg over time in hours. It compares placebo and Vardenafil 5 mg administered simultaneously or with a 6-hour separation, showing four lines with data points representing blood pressure changes over a 6-hour period.*

FDA Label Image

Figure 3 (Vardenafil Figure 4)

A line graph showing mean change in blood pressure (mmHg) over time (hours) for Vardenafil 5 mg and placebo under two conditions: simultaneous and 6-hour separation. The graph compares the effects on mean blood pressure from 0 to 6 hours post-dose with separate trend lines for each treatment and timing condition.*

FDA Label Image

Figure 4 (Vardenafil Figure 5)

A line graph showing mean change in measurement (mmHg) over time in hours (0 to 6) for placebo and Vardenafil at 10 mg and 20 mg doses across two stages of a study. The graph includes four data series marked with different symbols representing placebo and Vardenafil groups for stages 1 and 2.*

FDA Label Image

Figure 5 (Vardenafil Figure 6)

A line graph showing mean change in blood pressure (mmHg) over time (hours) for vardenafil 5 mg, vardenafil 10 mg, and placebo in two stages. The x-axis represents time from 0 to 6 hours, and the y-axis shows the mean change in mmHg from -10 to 10. Data points illustrate fluctuations in blood pressure response for each group across the study duration.*

FDA Label Image

Figure 6 (Vardenafil Figure 7)

A line graph showing the mean change in mmHg over time (in hours) for Terazosin under different conditions: placebo, 10 mg Vardenafil, and 20 mg Vardenafil, each with 6-hour separation and simultaneous administration. The graph tracks blood pressure changes from 0 to 6 hours post-dose.*

FDA Label Image

Figure 7 (Vardenafil Figure 8)

A line graph titled 'TAMSULOSIN' depicting the mean change in mmHg over time in hours for placebo, 10 mg Vardenafil, and 20 mg Vardenafil under both 6-hour separation and simultaneous administration conditions. The graph shows various trends in blood pressure changes over a 6-hour period with distinct line and marker styles for each group.*

FDA Label Image

Figure 8 (Vardenafil Figure 9)

A line chart showing plasma concentration (µg/L) versus time (hours) for Vardenafil Hydrochloride. Plasma concentration peaks early within the initial hours and then gradually declines to near zero by 24 hours, with error bars indicating variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.